Project BRAINIP

Basic data

Title:
BRAINIP
Duration:
01/11/2016 to 31/10/2019
Abstract / short description:
CA209-429 - An Open Label Phase 11 Study to Evaluate Safety and Efficacy of Combined Treatment with Ipilimumab and Nivolumab in Patients with Up to Five Brain Metastases
of Melanoma - BRAINIP-Trial

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Tampouri, Ioanna
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Spänkuch, Iris
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

München, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.